Skip to content
JCP
PCC
Insights
About
Authors & Reviewers
Sign In
Subscribe
Search
Advanced Search
Menu
JCP
PCC
Insights
About
Authors & Reviewers
Sign In
Subscribe
Sign in
Subscribe
Clinical Topics
View All
Addiction
ADHD
Alzheimer’s Disease
Anxiety
Bipolar Disorder
Depression
Movement Disorders
Neurology
OCD
Psychopharmacology
PTSD and Trauma
Schizophrenia/Schizoaffective Disorders
Sleep
Tardive Dyskinesia
View All
Collections
View All
Academic Highlights
Clinical & Practical Psychopharmacology
Early Career Psychiatrists
Evolving Psychedelic Paradigm
Focus on Childhood and Adolescent Mental Health
Focus on Geriatric Psychiatry
Focus on Psychotherapy
Focus on Suicide
Focus on Psychosis
Focus on Women’s Mental Health
JCP Podcast
Rounds in the General Hospital
View All
Aurélie Delacrétaz, PhD
JCP
Original Research
Cardiometabolic Health in Psychiatry
March 31, 2020
Psychiatric patients are susceptible to cardiovascular disease (CVD), but this risk is poorly understood. This study compared CVD risk in psychiatric patients taking weight gain-inducing drugs with that in...
Céline Dubath
,
Aurélie Delacrétaz
,
Anaïs Glatard
, et al
JCP
Original Research
Lipid Worsening in Adolescents Treated With SGAs
April 9, 2019
How bad is too bad? Lipid worsening of 5% or more in the early stages of treatment with SGAs predicts a negative metabolic outcome in adults. Is it the...
Philippe Conus
,
Aurélie Delacrétaz
,
Frederik Vandenberghe
, et al
JCP
Original Research
Importance of Early Weight Changes to Predict Long-Term Weight Gain During Psychotropic Drug Treatment
November 25, 2015
Armin von Gunten
,
Philippe Conus
,
Aurélie Delacrétaz
, et al
